Physician profile
John Paul Sheehy
NPI 1336588235
$1,948.46
in general payments reported to CMS, 2019-2025
10 companies · $65.09 in 2025
The $65.09 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,390 · 2020: $47.60 · 2021: $150 · 2023: $24.61 · 2024: $271 · 2025: $65.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Monteris Medical Corporation | $1,300.90 | 2019 | |
| Insightec,INC | $145.86 | 2024 | Exablate |
| Neuropace, INC. | $125.39 | 2024 | |
| Livanova USA, INC. | $95.45 | 2021-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Nevro Corp. | $67.94 | 2020-2021 | |
| Medtronic USA, INC. | $66.29 | 2019-2020 | |
| Boston Scientific Corporation | $49.10 | 2025 | General - Dbs |
| Integra Lifesciences Corporation | $41.47 | 2019 | |
| Medtronic, INC. | $40.07 | 2021 | |
| Globus Medical, INC. | $15.99 | 2025 | Omnia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sheehy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.